The U.S. mRNA therapeutics CDMO market is driven by biotech demand for mRNA in vaccines and cancer treatments, using CDMO services for cost-efficiency and faster market entry. Novel tech like automation and AI enhances production, while supportive regulations…
Zdroj: 📰 GlobeNewswire
| 